Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 65 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Plain-language summary

Background and objectives Smoking cessation is universally prioritized for the prevention of cardiovascular disease and cancer, but its impact on dementia risk remains uncertain. We aimed to evaluate the associations of smoking cessation and postcessation weight gain with long-term risk of dementia and cognitive trajectories. Methods We conducted a prospective cohort study using data from the US Health and Retirement Study (1995-2020). A total of 32,802 dementia-free adults (mean age 60.5 years [SD 10.7]; 57.1% female) were included. Smoking status and body weight were assessed biennially through structured interviews. The primary outcome was incident dementia identified using the Langa-Weir algorithm, and the secondary outcome was cognitive function measured on a 27-point scale. Results Over 25 years of follow-up (median 9.9 years, interquartile range 4.4-16.4 years), 5,868 dementia cases were documented. Compared with current smokers, individuals who quit during follow-up had a lower dementia risk after quitting (hazard ratio 0.84, 95% CI 0.73-0.95), similar to those who had quit before baseline (0.79, 0.72-0.87) and to never smokers (0.75, 0.69-0.83). The benefits of cessation were largely limited to participants with no or modest 2-year postcessation weight gain (≤5 kg). By contrast, the association of quitting accompanied by >10-kg weight gain was not statistically significant (1.33, 0.87-1.82). Restricted cubic spline analysis showed decreasing dementia risk with longer time since quitting, and the risk approached that of never smokers and plateaued at around 7 years after cessation. Cognitive trajectory analyses showed that quitting was associated with long-term slower cognitive decline (slope difference 0.19 points per decade, 95% CI 0.00-0.38) but no transient cognitive change (0.57; 95% CI -0.69 to 1.83), especially among those with minor weight gain (slope difference 0.23 per decade, 95% CI 0.03-0.43). Discussion Smoking cessation was associated with a sustained lower dementia risk and slower cognitive decline, comparable to never smokers and those without short-term risk increase. However, postcessation weight gain may attenuate these advantages, highlighting the need for weight management in cessation programs. These findings should be interpreted cautiously, given the potential residual confounding and measurement error.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 32,802 participants. In this long-term study, people who quit smoking had a lower risk of dementia than those who kept smoking, similar to the risk seen in people who had never smoked. Reported effect size: HR 0.84 (95% CI 0.73-0.95) for quitting during follow-up vs continuing to smoke.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Chen, H., Wang, J., Lai, S., Peng, G., Zong, G., Yuan, C., et al. (2026). Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study. Neurology. https://doi.org/10.1212/WNL.0000000000218123

Vancouver

Chen H, Wang J, Lai S, Peng G, Zong G, Yuan C, et al. Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study. Neurology. 2026. doi:10.1212/WNL.0000000000218123. PMID: 42160746.

BibTeX

@article{chen2026-42160746,
  author  = {Chen, H. and Wang, J. and Lai, S. and Peng, G. and Zong, G. and Yuan, C. and others},
  title   = {{Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study}},
  journal = {Neurology},
  year    = {2026},
  doi     = {10.1212/WNL.0000000000218123},
  pmid    = {42160746},
  url     = {https://doi.org/10.1212/WNL.0000000000218123}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In this long-term study, people who quit smoking had a lower risk of dementia than those who kept smoking, similar to the risk seen in people who had never smoked. The benefit appeared mostly in those who gained little or no weight after quitting, while quitting with more than 10 kg of weight gain showed no statistically significant link.

Study details

Limitations

Self-reported smoking and weight; dementia from a cognitive-test algorithm; the authors flag residual confounding and measurement error.

How this study scored 65/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 4 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 3 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 64 of the 98 points it could be judged on, which is 65 of 100. Total 65 of 100.64 of the 98 points we could judge = 65 of 100

Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 64 of the 98 points we could judge it on, which is 65 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Neurology)
Journal's citation record 4 / 4 Neurology: journal h-index 525 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 32,802 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.5 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 14.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Benyan Luo: h-index 41 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42160746)
Free to read — / 2 Access not recorded — left out of this score
Points 64 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 64 of the 98 points we could judge it on is 65 out of 100.
Total 65 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Prevention and risk from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →